Total planned funding: $386,401,543
Allocations
Countries/Regions
Eswatini | $386,401,543 |
Organizational Types
Private Contractor | $99,413,986 |
University | $77,569,543 |
NGO | $66,787,011 |
Unknown | $61,480,444 |
Own Agency | $45,477,038 |
Host Country Government Agency | $14,235,302 |
FBO | $11,602,230 |
Multi-lateral Agency | $6,812,042 |
Other USG Agency | $2,433,947 |
Implementing Agency | $590,000 |
Program Areas
Care | $110,792,358 |
Treatment | $104,431,950 |
Prevention | $73,384,036 |
Governance and Systems | $42,182,038 |
Management and Operations | $28,510,392 |
Testing | $27,100,769 |
Budget Codes
HTXS: Treatment: Adult Treatment | $84,028,171 |
HBHC: Care: Adult Care and Support | $44,927,335 |
HKID: Care: Orphans and Vulnerable Children | $38,445,218 |
HVMS: Management and Operations | $28,510,392 |
HVCT: Testing: HIV Testing and Counseling | $27,100,769 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $25,236,595 |
HVOP: Sexual Prevention: Other Sexual Prevention | $22,862,604 |
HVTB: Care: TB/HIV | $19,445,064 |
OHSS: Health Systems Strengthening | $17,646,093 |
HVSI: Strategic Information | $17,211,287 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $12,124,425 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $11,918,626 |
HTXD: Treatment: ARV Drugs | $11,064,689 |
PDTX: Treatment: Pediatric Treatment | $9,339,090 |
PDCS: Care: Pediatric Care and Support | $7,974,741 |
HLAB: Laboratory Infrastructure | $7,324,658 |
HMBL: Biomedical Prevention: Blood Safety | $1,241,786 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$66,509,273
Countries/Regions
Pact, Inc.:
$45,556,742
Countries/Regions
Not Available:
$42,667,591
Countries/Regions
Chemonics International:
$22,746,181
Countries/Regions